Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $21.31 million. The enterprise value is $18.96 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.60 million shares outstanding. The number of shares has increased by 2.08% in one year.
| Current Share Class | 10.60M |
| Shares Outstanding | 10.60M |
| Shares Change (YoY) | +2.08% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 12.80% |
| Owned by Institutions (%) | 44.59% |
| Float | 9.24M |
Valuation Ratios
The trailing PE ratio is 285.92 and the forward PE ratio is 100.50.
| PE Ratio | 285.92 |
| Forward PE | 100.50 |
| PS Ratio | 1.49 |
| Forward PS | 1.39 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 256.19 |
| EV / Sales | 1.34 |
| EV / EBITDA | 132.57 |
| EV / EBIT | 3,159.62 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.31, with a Debt / Equity ratio of 0.16.
| Current Ratio | 5.31 |
| Quick Ratio | 3.55 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 2.02 |
| Debt / FCF | n/a |
| Interest Coverage | 6.00 |
Financial Efficiency
Return on equity (ROE) is 0.87% and return on invested capital (ROIC) is 0.04%.
| Return on Equity (ROE) | 0.87% |
| Return on Assets (ROA) | 0.03% |
| Return on Invested Capital (ROIC) | 0.04% |
| Return on Capital Employed (ROCE) | 0.06% |
| Revenue Per Employee | $456,839 |
| Profits Per Employee | $2,387 |
| Employee Count | 31 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 2.14 |
Taxes
In the past 12 months, Nephros has paid $15,000 in taxes.
| Income Tax | 15,000 |
| Effective Tax Rate | 16.85% |
Stock Price Statistics
The stock price has decreased by -8.22% in the last 52 weeks. The beta is 1.05, so Nephros's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -8.22% |
| 50-Day Moving Average | 1.70 |
| 200-Day Moving Average | 1.70 |
| Relative Strength Index (RSI) | 59.42 |
| Average Volume (20 Days) | 11,328 |
Short Selling Information
The latest short interest is 11,427, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 11,427 |
| Short Previous Month | 21,018 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 0.89 |
Income Statement
In the last 12 months, Nephros had revenue of $14.16 million and earned $74,000 in profits. Earnings per share was $0.01.
| Revenue | 14.16M |
| Gross Profit | 8.72M |
| Operating Income | 6,000 |
| Pretax Income | -1.29M |
| Net Income | 74,000 |
| EBITDA | 143,000 |
| EBIT | 6,000 |
| Earnings Per Share (EPS) | $0.01 |
Full Income StatementBalance Sheet
The company has $3.76 million in cash and $1.41 million in debt, giving a net cash position of $2.35 million or $0.22 per share.
| Cash & Cash Equivalents | 3.76M |
| Total Debt | 1.41M |
| Net Cash | 2.35M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 8.59M |
| Book Value Per Share | 0.81 |
| Working Capital | 6.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$492,000 and capital expenditures -$55,000, giving a free cash flow of -$547,000.
| Operating Cash Flow | -492,000 |
| Capital Expenditures | -55,000 |
| Free Cash Flow | -547,000 |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is 61.59%, with operating and profit margins of 0.04% and 0.52%.
| Gross Margin | 61.59% |
| Operating Margin | 0.04% |
| Pretax Margin | 0.63% |
| Profit Margin | 0.52% |
| EBITDA Margin | 1.01% |
| EBIT Margin | 0.04% |
| FCF Margin | n/a |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.08% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.35% |
| FCF Yield | -2.57% |
Analyst Forecast
The average price target for Nephros is $5.00, which is 148.76% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 148.76% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.
| Last Split Date | Jul 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1111111:1 |
Scores
Nephros has an Altman Z-Score of -10.76 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.76 |
| Piotroski F-Score | 4 |